WELL Health Technologies (TSE:WELL) Reaches New 12-Month High Following Analyst Upgrade

WELL Health Technologies Corp. (TSE:WELL)’s stock price reached a new 52-week high during trading on Monday after Scotiabank raised their price target on the stock from C$6.00 to C$7.00. The company traded as high as C$7.05 and last traded at C$7.02, with a volume of 967704 shares traded. The stock had previously closed at C$6.79.

Several other analysts have also recently issued reports on the company. Haywood Securities increased their price objective on WELL Health Technologies from C$8.00 to C$10.00 in a research note on Friday. Ventum Financial reduced their price objective on WELL Health Technologies from C$8.00 to C$7.00 and set a “buy” rating on the stock in a research note on Tuesday, October 29th. Finally, CIBC increased their price objective on WELL Health Technologies from C$5.25 to C$7.00 in a research note on Friday.

WELL Health Technologies Stock Up 2.9 %

The stock has a market cap of C$1.74 billion, a PE ratio of 12.26, a price-to-earnings-growth ratio of -1.93 and a beta of 1.20. The firm has a fifty day moving average of C$5.19 and a 200 day moving average of C$4.71. The company has a quick ratio of 1.02, a current ratio of 1.25 and a debt-to-equity ratio of 41.57.

WELL Health Technologies Company Profile

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.